Marbls

Our company, Marbls, is five (5) years old and we just couldn’t be happier! The best thing about our company is the great people we work with daily on our team. They are super nice, from various parts of the world, and really great at what they do in Life Sciences.    A big thanks to our clients and partners. We look forward to many years to come!   Please take a look as #ourteam, says “Hi!” Ralph Lynn Arnab Sikder

From #ourteam at Marbls, wishing our clients and partners a Happy Holiday Season and all the best for the New Year. We are especially thankful for our colleagues and excited for what’s to come in 2025! #lifesciences #pricing #contracting #holidays Arnab Sikder Ralph Lynn

The holiday season continues to be special with a great evening for our Marbls team in New York City - #ourteam. #lifesciences #pricing #contracting #holidays Ralph Lynn Arnab Sikder

A special start to the Marbls holiday season with our holiday party and the annual Course de l'Escalade race in Geneva, Switzerland - #ourteam. #lifesciences #pricing #contracting #coursedelescalade #tradition Arnab Sikder Ralph Lynn

Our Marbls Christmas party three years ago and this year! It is so nice to see the team growing 🤗

A special start to the Marbls holiday season with our holiday party and the annual Course de l'Escalade race in Geneva, Switzerland - #ourteam. #lifesciences #pricing #contracting #coursedelescalade #tradition Arnab Sikder Ralph Lynn

Our very own, Mathilde CHEVALLIER, Senior Manager at Marbls, is an Agent leading the charge! To learn how Marbls is enabling Salesforce and AgentForce to meet the needs of our Life Science clients please reach out to Mathilde, or any of our Marbls resources from our Tech Hub! #lifesciences #pricing #contracting #salesforce #trailblazer #princetonnj #geneva #wth #lisbon Markus Nigl Ralph Lynn Arnab Sikder

Our Marbls team would like to wish all of our clients, partners, and colleagues a very happy Thanksgiving!  We have much to be grateful for this year and couldn’t be more appreciative of all the dedicated individuals who we work with on a regular basis. Have a safe and happy holiday with your friends and family, and thank you for the continued support! #ourteam #lifesciences # #pricing #princetonnj #geneva #wth #lisbon   Ralph Lynn Arnab Sikder

State Price Transparency – New Jersey Operationalizes Drug Price Transparency Legislation! On October 15, 2024, New Jersey operationalized their state price transparency legislation (S 1615). While the bill was enacted in July 2023, the provisions were set to go into effect on August 1, 2024. However, the NJ Drug Affordability Unit (DAU), the department responsible for administering the reporting program only launched their website and published a reporting guide and templates on October 15, 2024.   Implications for Manufacturers:   Under this law, manufacturers must submit data pertaining to drugs that undergo triggering price increases or launches. New Jersey has set up their reporting using a two-phased approach, with an initial notification due within 10 days of the price increase/market introduction and a subsequent report due within 20 days of the price increase/market introduction. The thresholds for qualifying reporting are as follows: Branded Drugs: o  Price increase of greater than 10% per pricing unit during any 12-month period Generic Drugs: o  Wholesale acquisition cost (WAC) greater than $10 but less than $100 per pricing unit and a price increase of more than 40% during any 12-month period o  WAC greater than $100 per pricing unit and a price increase of more than 10% during any 12-month period Drug Launches: o  Branded and generic drugs with a WAC exceeding the threshold set for a specialty-tier drug under Medicare Part D o  Biosimilar drugs with a WAC that is not at least 15% less than the WAC of the referenced brand biologic at the time the biosimilar is launched Per the DAU’s website, even though the department’s website, templates, and user guide were not posted until October 15, 2024, manufacturers are expected to comply with the statutory requirements for all price increases and drug launches that occurred starting on August 1, 2024 when the requirements went into effect. At this time all reporting is to be submitted to the Drug Affordability Unit via email. In addition to all reporting requirements under the legislation, reporting entities must also register with the DAU annually by January 31st.   Please reach out to our team Ritu Pandey and Patrick Citrano, MS for additional insight and perspective. Additional information on existing legislation and updates around new legislation can always be found on our free State Drug Pricing App on the App Store (https://lnkd.in/gsFJ7h7) and Google Play (https://lnkd.in/ghdJrNz). #lifesciences #drugpricing #drugprices #mobileapps #transparency #ourteam Ralph Lynn Arnab Sikder

It was an exciting and packed week for our Marbls team exhibiting at ISPOR Europe 2024 in Barcelona this week! It is an event that continues to focus on health economics and outcomes research (HEOR) to support innovation and access to healthcare globally. Topics this year especially centered on perspectives and practical impacts regarding the upcoming Joint Clinical Assessments, whether GenerativeAI and LLMs are impacting the process with HTAs, developments on policy, and continuing Digital Transformation within our space.  Our colleagues Eva Wilson, Raquel Cunha Santos, and Ruven Remo Eul spent quality time with existing clients and partners and had the opportunity to meet many new peers. To read out latest perspectives on the JCA, please download our recent paper at https://lnkd.in/eXdNQEHw  Please contact Eva, Raquel, or Ruven or reach us at themarblsteam@marblsgroup.com to discuss any relevant topics with our team.  #lifesciences #pricing #contracting #marketaccess #HEOR #jca #ourteam Arnab Sikder Ralph Lynn